Cavotec AS is a Swiss company listed company on Nasdaq Stockholm, Sweden. The objective for Cavotec is to apply the Swedish Corporate Governance Code (“the Code”), while still respecting Swiss laws and regulations applicable to a Swiss company.
The composition of Cavotec’s Nomination Committee follows the recommendations of the Code.
Ahead of the annual general meeting, the names of the members of the nomination committee and shareholders they represent are to be announced by the company not later than six months before the annual general meeting.
Cavotec’s Nomination Committee ahead of Annual General Meeting 2024
The Nomination Committee of Cavotec SA consists of members appointed by Cavotec’s Board of Directors, in accordance with Cavotec's Internal Regulations. Furthermore, the composition of the members of the Nomination Committee presented below is in line with the recommendations of the Swedish Corporate Governance Code. The main purpose and responsibility of the Nomination Committee is to present proposals for the election and remuneration of the Chairman, the Board of Directors and the Auditors at the Annual General Meeting to be held in 2024.
The Board of Directors has decided that the shareholders, representing 66.1% of the vote, and the Chairman of Cavotec’s Board of Directors shall be represented in the Nomination Committee. On October 5, 2023, the four largest shareholders were Bure Equity AB (35.2% of the vote), TomEqt Private (Thomas von Koch) (17.4% of the vote), Nomina SA (7.1% of the vote) and The Fourth Swedish National Pension Fund (AP4) (6.4% of the vote).
Upon nomination from the major shareholders, the Board of Directors has appointed the following representatives to the Nomination Committee:
Henrik Blomquist, who represents Bure Equity AB
Fabio Cannavale, who represents Nomina SA
Per Colleen, who represents TomEqt Private (Thomas von Koch)
Thomas Ehlin, who represents The Fourth Swedish National Pension Fund (AP4)
Patrik Tigerschiöld, Chairman of Cavotec’s Board of Directors
The above calculation is based on 106,696,030 shares which represents the total number of ordinary shares in Cavotec.
Cavotec’s Annual General Meeting for the financial year 1 January 2023 – 31 December 2023 will be held on 4 June 2024. In order for the Nomination Committee to be able to evaluate the proposals received with due care, proposals must be submitted by no later than 17 April 2024. The Nomination Committee’s proposals will be presented in the Notice convening the Annual General Meeting 2024 and on the company’s website.
Shareholders in Cavotec should send proposals to the Nomination Committee by email to firstname.lastname@example.org.